Tumor-specific cytotoxicity of 3,5-dibenzoyl-1,4-dihydropyridines

Anticancer Research

Volumn 25, Issue 3 B, 2005, Pages 2033-2038

  Morshed, Sufi Reza M D ^a,f   Hashimoto, Ken ^a   Murotani, Yukie ^b   Kawase, Masami ^b   Shah, Anamik ^c   Satoh, Kazue ^d   Kikuchi, Hirotaka ^a   Nishikawa, Hirofumi ^c   Maki, Jun ^e   Sakagami, Hiroshi ^a  

^a MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^b JOSAI UNIVERSITY   (Japan)

^c SAURASHTRA UNIVERSITY   (India)

^d SHOWA UNIVERSITY   (Japan)

^e KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

3,5 Dibenzoyl 1,4 dihydropyridines; Bad; Bax; Bcl 2; Caspase; DNA fragmentation; Radical; Tumor specificity

Indexed keywords

1 HYDROXY 2 OXO 3 (N 3 METHYL 3 AMINOPROPYL) 3 METHYL 1 TRIAZENE; 3,5 DIBENZOYL 1,4 DIHYDROPYRIDINE DERIVATIVE; 4 (2' TRIFLUOROMETHYLPHENYL) 3,5 DIBENZOYL 2,6 DIMETHYL 1,4 DIHYDROPYRIDINE; 4 (3' CHLORPHENYL) 3,5 DIBENZOYL 2,6 DIMETHYL 1,4 DIHYDROPYRIDINE; CASPASE 3; CASPASE 8; CASPASE 9; CYTOTOXIC AGENT; DIHYDROPYRIDINE DERIVATIVE; NITRIC OXIDE; PROTEIN BAD; PROTEIN BAX; SUPEROXIDE; TRIAZENE DERIVATIVE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ELECTRON SPIN RESONANCE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; SQUAMOUS CELL CARCINOMA; SUBMANDIBULAR GLAND; TUMOR CELL LINE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DIHYDROPYRIDINES; DRUG SCREENING ASSAYS, ANTITUMOR; FIBROBLASTS; FREE RADICAL SCAVENGERS; HL-60 CELLS; HUMANS; NITRIC OXIDE; SUBMANDIBULAR GLAND NEOPLASMS; SUPEROXIDES;

EID: 21344472781     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bessert F, Meyer H and Wehinger E: 4-Aryldihydropyridine, a new class of highly active calcium antagonists. Angew Chem Int Ed Engl 20: 762-769, 1981.
2. Godfraid T, Miller R and Wibo M: Calcium antagonism and calcium entry blockade. Pharmacol Rev 38: 321-416, 1986.
3. Mager PP, Coburn RA, Solo AJ, Triggle DJ and Rothe H: QSAR, diagnostic statistics and molecular modelling of 1,4-dihydropyridine calcium antagonists: a difficult road ahead. Drug Design Discovery 8: 273-289, 1992.
4. Ogawa AK, Willoughby CA, Bergeron R, Ellsworth KP, Geissler WM, Myers RW, Yao J, Harris G and Chapman KT: Glucose-lowering in a db/db mouse model by dihydropyridine diacid glycogen phosphorylase inhibitors. Bioorg Med Chem Lett 13: 3405-3408, 2003.
5. Sabitha G, Reddy GSKK, Reddy CS and Yadav JS: A novel TMSI-mediated synthesis of Hantzsch 1,4-dihydropyridines at ambient temperature. Tetrahedron Lett 44: 4129-4131, 2003.
6. Tewari N, Dwivedi N and Tripathi RP: Tetrabutylammonium hydrogen sulfate catalyzed eco-friendly and efficient synthesis of glycosyl 1,4-dihydropyridines. Tetrahedron Lett 45: 9011-9014, 2004.
7. Desai B, Sureja D, Naliapara Y, Shah A and Saxena A: Synthesis and QSAR studies of 4-substituted phenyl-2,6-dimethyl-3,5-bis-N-(substituted phenyl)carbamoyl-1,4-dihydropyridines as potential antitubercular agents. Bioorg Med Chem 9: 1993-1998, 2001.
8. Kharkar PS, Desai B, Gaveria H, Varu B, Loriya R, Naliapara Y, Shah A and Kulkarni VM: Three-dimensional quantitative structure-activity relationship of 1,4-dihydropyridines as antitubercular agents. J Med Chem 45: 4858-4867, 2002.
9. Shah A, Gaveriya H, Motohashi N, Kawase M, Saito S, Sakagami H, Satoh K, Tada Y, Solymosi A, Walfard K and Molnar J: 3,5-Diacetyl-1,4-dihydropyridines: synthesis and MDR reversal in tumor cells. Anticancer Res 20: 373-378, 2000.
10. Tasaka S, Ohmori H, Gomi N, Iino M, Machida T, Kiue A, Naito S and Kuwano M: Synthesis and structure-activity analysis of novel dihydropyridine derivatives to overcome multidrug resistance. Bioorg Med Chem Lett 11: 275-277, 2001.
11. Kawase M, Shah A, Gaveriya H, Motohashi N, Sakagami H, Varga A and Molnar J: 3,5-Dibenzoyl-1,4-dihydropyridines: synthesis and MDR reversal in tumor cells. Bioorg Med Chem 10: 1051-1055, 2002.
12. Saponara S, Kawase M, Shah A, Motohashi N, Molnar, Ugocsai K, Sgaragli G and Fusi F: 3,5-Dibenzoyl-4-(3-phenoxyphenyl)-1,4-dihydro-2,6-dimethylpyridine (DP7) as a new multidrug resistance reverting agent devoid of effects on vascular smooth muscle contractility. Br J Pharmacol 141: 415-422, 2004.
13. Yanagisawa-Shiota F, Sakagami H, Kuribayashi N, Iida M, Sakagami T and Takeda M: Endonuclease activity and induction of DNA fragmentation in human myelogenous leukemic cell lines. Anticancer Res 15: 259-266, 1995.
14. Schwall R, Sinicropi D and Ashkenazi A: Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. Nature Med 8: 274-281, 2002.
15. Kaiser J: Sipping from a poisoned chalice. Science 302: 376-379, 2003.
16. Shintani T and Klionsky DJ: Autophagy in health and disease: a double-edged sword. Review. Science 306: 990-995, 2004.
17. Sakagami H, Chowdhury SA, Suzuki F, Hashimoto K, Hatano H, Takekawa H, Ishihara M, Kikuchi H, Nishikawa H, Taniguchi S, Ito H, Hatano T, Yoshida T, Fukai T, Shirataki Y, Kawase M, Watanabe K, Mimaki Y, Itoh K, Horiuchi A, Chai W, Horiuchi A and Motohashi N: Tumor-specific cytotoxic activity of polyphenols, terpenoids, ketones and other synthetic compounds. (Review) Functional Polyphenols with Antioxidative Action, a review book series of "Chem. Pharmaceutical Sciences (CPS), ed., Motohashi" ("REFLASH", India) (ed.), in press.